最新发布

Galderma survey finds skin quality concerns affect 90% of people globally

A global survey has revealed that nine out of 10 people are affected by skin quality concerns. In its research, dermatology company Galderma found that skin quality concerns are highly common, can pose mental health effects, and are often comparable among people in similar demographics by age, lifestyle, and environment.

Henkel finalizes Olaplex deal amid premium hair care push

Henkel has finalized the acquisition of Olaplex. The deal’s completion fully designates Olaplex as a part of Henkel, marking a step in the German consumer goods conglomerate’s growth agenda.

Epigenomic Analysis Uncovers New AML Subgroups and Drug Sensitivities

As one of the most aggressive blood cancers, the way acute myeloid leukemia (AML) is classified continues to shape every major clinical decision—from risk stratification to the choice of targeted therapies. For decades, that classification has rested almost entirely on the gene mutations found in leukemic cells. But mutations alone have never fully explained why AML behaves so differently from patient to patient. A new study published in Nature now provides the missing layer: the epigenome.

🎥 Inside Faraday Earth’s bid to make cheap green ammonia without Haber-Bosch

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Faraday Earth] Can a container-sized plasma reactor…

美国农业部动植物卫生检验局宣布对1项转基因柑橘砧木解除管制

世界农化网中文网报道:2026年6月30日,美国农业部动植物卫生检验局(APHIS)发布公告,决定解除对Soil Culture Solutions公司开发的CarriCea Carrizo柑橘砧木的管制。该砧木采用CRISPR/Cas9基因编辑技术开发,通过敲除Lls1、ACD2和CP等内源基因,增强其对柑橘黄龙病(Huanglongbing,又称citrus greening disease)的抗性。

AstraZeneca and Ionis miss in key ATTR-CM trial

Why it matters: The result weakens AstraZeneca’s attempt to expand eplontersen beyond hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN), where the drug is already approved in more than 20 countries, including in the EU as Wainzua.

Queensland Took Center Stage as Global AgInvesting Conference Debuted in Brisbane

By Editor, Global AgInvesting MediaIn a major milestone for the Southern Hemisphere, Global AgInvesting (GAI) Australia, the world’s premier agricultural investment event, kicked off in Brisbane this June. The event marked the first time the prestigious global forum had been held outside the Northern Hemisphere, positioning Queensland at the forefront of international agribusiness and capital investment.

🎥 Can non thermal plasma seed treatment move from lab curiosity to broadacre reality?

[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Sylvarum] Using non-thermal plasma or high voltage …

Stem Cell Therapy Shows Promise in First Human Parkinson’s Disease Trial

Parkinson’s Disease as a progressive neurological disorder affecting body movement and coordination as neuron cells losing function in the substantia nigra section of the human brain as a degenerative illness.[wildpixel/Getty Images]

GSK ends Alector neuroscience deal after trial failures

Why it matters: The move is another reminder of how difficult neurodegeneration remains for big pharma, even as Alzheimer’s and dementia research attracts renewed investment after the first disease-modifying amyloid drugs reached the market.